General Information of the Compound
| Compound ID |
CP0185533
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-((3R,4R)-3-(((S)-3-(4-fluorobenzyl)piperidin-1-yl)methyl)-1-(1-acetylpiperidin-4-yl)piperidin-4-yl)-3-(5-acetyl-4-methylthiazol-2-yl)urea
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H45FN6O3S
|
||||||||||||||||||
| Molecular Weight |
612.816
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)N1CCC(CC1)N1CC[C@@H](NC(=O)Nc2nc(C)c(s2)C(C)=O)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H45FN6O3S/c1-21-30(22(2)40)43-32(34-21)36-31(42)35-29-12-16-39(28-10-14-38(15-11-28)23(3)41)20-26(29)19-37-13-4-5-25(18-37)17-24-6-8-27(33)9-7-24/h6-9,25-26,28-29H,4-5,10-20H2,1-3H3,(H2,34,35,36,42)/t25-,26+,29+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
SEGSTAYQKLCBCH-IWVFXYMLSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound